JWM
REGN icon

JPL Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

JPL Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.73K Sell
14
-11
-44% -$7.49K ﹤0.01% 625
2026
Q1 		$19.3K Buy
+25
New +$19.1K ﹤0.01% 402
2025
Q4 		– Sell
-12
Closed -$6.75K – 893
2025
Q3 		$6.75K Buy
+12
New +$6.79K ﹤0.01% 606

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

JPL Wealth Management's REGN Position: Q2 2026 in Review

JPL Wealth Management reduced its Regeneron Pharmaceuticals (REGN) stake by 44% in Q2 2026, selling an estimated $7.49K and leaving 14 shares worth $8.73K. The position accounts for ﹤0.01% of the portfolio, ranked #625.

JPL Wealth Management first reported a position in REGN in Q3 2025 and has held it in 3 quarters since. The position peaked at $19.3K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • JPL Wealth Management held 14 shares of Regeneron Pharmaceuticals worth $8.73K as of Q2 2026.
  • JPL Wealth Management sold 11 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $7.49K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of JPL Wealth Management's portfolio in Q2 2026, its #625 holding.
  • JPL Wealth Management first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • JPL Wealth Management's Regeneron Pharmaceuticals position peaked at $19.3K in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.